Curable compositions

US12486349B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12486349-B2
Application numberUS-202017756865-A
CountryUS
Kind codeB2
Filing dateDec 3, 2020
Priority dateDec 5, 2019
Publication dateDec 2, 2025
Grant dateDec 2, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a curable composition including the following components: (i) a first alkoxysilane which is unhydrolyzed; (ii) a second alkoxysilane which is 5 to 45 percent hydrolyzed; and (iii) an ethylenically unsaturated monomer. The invention also provides coatings formed from the curable composition and articles coated with the curable composition.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A curable composition comprising the following components: (i) a first alkoxysilane which is unhydrolyzed, present in the curable composition in an amount ranging from 10 to 80 weight percent; (ii) a second alkoxysilane which is 5 to 45 percent hydrolyzed, present in the curable composition in an amount ranging from 5 to 90 weight percent; and an ethylenically unsaturated monomer, present in the curable composition in an amount ranging from 1 to 50 weight percent; wherein weight percentage is based on the total weight of components (i), (ii), and (iii). 2 . The curable composition of claim 1 , wherein component (i) and component (ii) are prepared and added separately. 3 . The curable composition of claim 1 , wherein component (ii) comprises at least 30 percent monomeric alkoxysilane. 4 . The curable composition of claim 1 , wherein the first alkoxysilane and the second alkoxysilane are the same or different. 5 . The curable composition of claim 1 , wherein the first alkoxysilane and the second alkoxysilane each independently has the following structure (I): R x Si(OR′) 4-x   (I) wherein: x is 0, 1, 2, or 3; each R is an organic radical independently selected from C 1 to C 6 alkyl, vinyl, alkoxyalkyl, aryl, aryloxyalkyl, γ-glycidoxy alkyl, or γ-(meth)acryloxy alkyl; and each R′ is independently a C 1 to C 4 alkyl group. 6 . The curable composition of claim 1 , further comprising a free-radical initiator selected from the group consisting of thermal initiators, photoinitiators, and mixtures thereof. 7 . The curable composition of claim 6 , wherein the free-radical initiator is a photoinitiator. 8 . The curable composition of claim 1 , wherein each of the first alkoxysilane of component (i) and the second alkoxysilane of component (ii) is independently selected from the group consisting of methyl triethoxysilane, γ-glycidoxypropyl trimethoxysilane, tetramethoxysilane, tetraethoxysilane, acryloxysilane, and mixtures thereof. 9 . The curable composition of claim 5 , wherein R is γ-glycidoxy alkyl and the curable composition further comprises a curing agent comprising a cationic initiator. 10 . The curable composition of claim 9 , wherein the curing agent comprises aryl onium salts of Group VA elements, salts of Group VIA elements, salts of Group VIIA elements, or mixtures thereof. 11 . The curable composition of claim 1 , wherein the ethylenically unsaturated monomer of component (iii) is selected from the group consisting of hexanediol diacrylate, butanediol diacrylate, cycylohexane dimethanol divinylether, and mixtures thereof. 12 . The curable composition of claim 1 , wherein the second alkoxysilane of component (ii) is 10 to 40 percent hydrolyzed. 13 . The curable composition of claim 1 , further comprising a polyglycidyl ether.

Assignees

Inventors

Classifications

  • C09D183/06Primary

    containing silicon bound to oxygen-containing groups (C09D183/12 takes precedence) · CPC title

  • {Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond} in combination with a macromolecular compound other than an unsaturated polymer of groups C09D159/00 - C09D187/00 · CPC title

  • of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate · CPC title

  • on to saturated polysiloxanes containing hydrolysable groups, e.g. alkoxy-, thio-, hydroxy- · CPC title

  • {Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond} in combination with a macromolecular compound other than an unsaturated polymer of groups C09J159/00 - C09J187/00 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12486349B2 cover?
Provided is a curable composition including the following components: (i) a first alkoxysilane which is unhydrolyzed; (ii) a second alkoxysilane which is 5 to 45 percent hydrolyzed; and (iii) an ethylenically unsaturated monomer. The invention also provides coatings formed from the curable composition and articles coated with the curable composition.
Who is the assignee on this patent?
Ppg Ind Ohio Inc
What technology area does this patent fall under?
Primary CPC classification C09D183/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).